Sinopharm Group Reports Mixed Financial Results
Company Announcements

Sinopharm Group Reports Mixed Financial Results

Sinopharm Group Co (HK:1099) has released an update.

Sinopharm Group Co. reported a slight revenue increase of 2.65% for the quarter ending September 2024, but experienced a significant drop in operating profit by 25.05% compared to the same period last year. Despite a 9.27% increase in total assets, the net profit attributable to shareholders decreased by 10.39%, reflecting challenges in the company’s profitability.

For further insights into HK:1099 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks HongKong Auto-Generated NewsdeskSinopharm Group Co. Reports Mixed Financial Results
TipRanks HongKong Auto-Generated NewsdeskSinopharm Group’s Asset Growth Boosts Investor Confidence
TipRanks HongKong Auto-Generated NewsdeskSinopharm Subsidiary Faces Revenue and Profit Declines
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App